Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 76

Results For "NIV"

978 News Found

Sara Gutierrez joins SHL as the Chief Science Officer
People | March 30, 2022

Sara Gutierrez joins SHL as the Chief Science Officer

The science leader comes with a rich experience in the employment testing industry


X-Chem’s Noor Shaker awarded for achievements in AI for drug discovery
News | March 30, 2022

X-Chem’s Noor Shaker awarded for achievements in AI for drug discovery

Shaker is one of six receiving an individual award, which recognizes people, organizations and products bringing AI to life and applying it to solve real problems


Govt signs agreement with Sapigen Biologix to develop two vaccines
News | March 28, 2022

Govt signs agreement with Sapigen Biologix to develop two vaccines

Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project


EU approves Evusheld to prevent Covid-19
Drug Approval | March 28, 2022

EU approves Evusheld to prevent Covid-19

Evusheld significantly reduced the risk of developing symptomatic COVID-19 in PROVENT Phase III trial, with protection lasting at least six months


Philips expands network of clinical partners for early diagnosis and treatment of lung cancer
Medical Device | March 28, 2022

Philips expands network of clinical partners for early diagnosis and treatment of lung cancer

Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases


New spesolimab data show promising results in patients with generalised pustular psoriasis flares
Biotech | March 28, 2022

New spesolimab data show promising results in patients with generalised pustular psoriasis flares

Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status


Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis
Biotech | March 27, 2022

Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis

There are currently no approved systemic treatments for prurigo nodularis; regulatory filings for prurigo nodularis planned in the first half of 2022


HaystackAnalytics sees alarming rise in TB cases
Healthcare | March 24, 2022

HaystackAnalytics sees alarming rise in TB cases

A staggering 65% of the TB cases in India are in the 15-45 age group


Seven ways the pharma industry can benefit from tech-driven logistics solutions
Opinion | March 24, 2022

Seven ways the pharma industry can benefit from tech-driven logistics solutions

The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable


Study shows green Mediterranean diet modifies bacterial population in gut
Biotech | March 23, 2022

Study shows green Mediterranean diet modifies bacterial population in gut

The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine